| Not Yet Recruiting | A Study to Characterize Encorafenib Plus Cetuximab as Rechallenge Treatment for BRAF V600E-mutant Metastatic C Colo-rectal Cancer | Phase 2 | 2025-10-01 |
| Recruiting | Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL Melanoma, Non Small Cell Lung Cancer, Cervical Cancer | Phase 2 | 2025-01-15 |
| Recruiting | A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Adminis Osteosarcoma, Osteosarcoma in Children | Phase 2 | 2024-12-27 |
| Recruiting | Combination Therapy for BRAF-V600E Metastatic CRCm Metastatic Colorectal Cancer | Phase 2 | 2024-05-17 |
| Withdrawn | Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer Endometrial Cancer | Phase 1 / Phase 2 | 2024-05-01 |
| Recruiting | Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial) Ovarian Cancer | Phase 2 | 2024-02-06 |
| Recruiting | Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Plat Triple Negative Breast Cancer | — | 2023-01-13 |
| Terminated | A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients Wit Breast Neoplasms | Phase 1 | 2022-05-11 |
| Recruiting | Single cEll pRofiling PErsistaNce To ImmuNothErapy Colorectal Cancer, Endometrial Cancer | Phase 2 | 2022-03-01 |
| Recruiting | Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Ly Epithelial Tumors, Malignant, Malignant Solid Tumor | EARLY_Phase 1 | 2021-10-28 |
| Unknown | Machine Learning Model to Predict HOLS and Mortality After Discharge in Hospitalized Oncologic Patients Solid Tumor, Nutrition Related Neoplasm/Cancer, Comorbidities and Coexisting Conditions | — | 2020-02-15 |
| Active Not Recruiting | Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gast Gastroesophageal Junction Adenocarcinoma, Stomach Neoplasms | Phase 2 | 2019-08-22 |
| Recruiting | A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets) Advanced Solid Tumor | Phase 2 | 2018-12-10 |
| Unknown | Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Prostate Cancer Metastatic | N/A | 2018-09-01 |
| Completed | Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer Endometrial Neoplasms | Phase 2 | 2018-05-30 |
| Terminated | Study With Atezolizumab Plus Bevacizumab in Patients With Chemotherapy Resistant, MSI-like, Colorectal Cancer MSI, ColoRectal Cancer, Chemotherapy | Phase 2 | 2017-11-24 |